Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: A GITMO survey on 809 patients autografted in first complete remission

Academic Article

Publication Date:

2017

Iris type:

1.1.2. Articolo in Rivista - Letter, Note

List of contributors:

Saraceni, F.; Bruno, B.; Lemoli, R. M.; Meloni, G.; Arcese, W.; Falda, M.; Ciceri, F.; Alessandrino, E. P.; Specchia, G.; Scime, R.; Raimondi, R.; Bacigalupo, A.; Bosi, A.; Onida, F.; Rambaldi, A.; Bonifazi, F.; Olivieri, A.

Authors of the University:

CICERI FABIO

Handle:

https://iris.unisr.it/handle/20.500.11768/138304

Published in:

BONE MARROW TRANSPLANTATION

Journal

Overview

URL

https://www.nature.com/articles/bmt2016233